Genetic and other omics-based information in the most-cited recent clinical trials
Luigi Russo, Salvatore Farina, Leonardo Maria Siena, Roberta Pastorino, Stefania Boccia, John P. A. Ioannidis
This study examines the use of genetic and other omics information in highly cited clinical trials, finding that 22% of trials used such data, mostly in oncology, with significant industry involvement and limited transparency.
European Journal of Public Health · Oct 28, 2024Peer-reviewedGenetic & Genomic Medicine